NCT00909428View on ClinicalTrials.gov

Validation of a Real-time Urodynamic Measure of Urinary Urgency

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2009

Conditions
Overactive Bladder Syndrome
Interventions
DRUG

Solifenacin Succinate

Participants take 10mg daily solifenacin succinate for 30 days

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

Sponsors

Collaborators (1)

Astellas Pharma Inc
All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Loyola University

OTHER

NCT00909428 - Validation of a Real-time Urodynamic Measure of Urinary Urgency | Biotech Hunter | Biotech Hunter